CD133 mRNA expression appears to be an independent prognostic factor for overall survival, as increased levels were detected in the peripheral blood of cancer patients with bone metastasis (Mehra etal, 2006) and were shown to predict colon cancer recurrence (Lin et al, 2007). This evidence concerns the gene PROM1 and cancer.